Opko enters into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx). Opko says the purchase agreement is secured by its profit share payments from Pfizer received ...

OPKO Health (OPK) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

OPKO Health (OPK) is back on investors’ radar after a recent move in its share price. This has prompted closer attention to ...

The most recent short interest data was recently released by the NASDAQ for the 08/30/2013 settlement date, and Opko Health Inc (NYSE: OPK) is one of the most shorted stocks of the Russell 3000, based ...

We recently compiled a list of the 10 Best Stocks Under $3 to Buy Now. In this article, we are going to take a look at where ...

OPKO Health, Inc. OPK posted earnings per share of 3 cents for the third quarter of 2025, flat year over year. Earnings beat the Zacks Consensus Estimate of a loss of 2 cents per share by 250.00%.

OPKO Health Inc. Annual cash flow by MarketWatch. View OPK net cash flow, operating cash flow, operating expenses and cash dividends.

Investors in OPKO Health Inc (Symbol: OPK) saw new options become available today, for the December 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK ...

In the financial world, there are many reasons why corporate insiders would choose to sell their company’s stock, but only one reason why they would choose to buy. Over the past decade, there has been ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.